1
|
Chen J, Garcia EJ, Merritt CR, Zamora JC, Bolinger AA, Pazdrak K, Stafford SJ, Mifflin RC, Wold EA, Wild CT, Chen H, Anastasio NC, Cunningham KA, Zhou J. Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5-HT 2C Receptor and Dual 5-HT 2C/5-HT 2A Receptor Modulators. J Med Chem 2023; 66:9992-10009. [PMID: 37462530 PMCID: PMC10853020 DOI: 10.1021/acs.jmedchem.3c00908] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/28/2023]
Abstract
The serotonin 5-HT2A receptor (5-HT2AR) and 5-HT2CR localize to the brain and share overlapping signal transduction facets that contribute to their roles in cognition, mood, learning, and memory. Achieving selective targeting of these receptors is challenged by the similarity in their 5-HT orthosteric binding pockets. A fragment-based discovery approach was employed to design and synthesize novel oleamide analogues as selective 5-HT2CR or dual 5-HT2CR/5-HT2AR positive allosteric modulators (PAMs). Compound 13 (JPC0323) exhibited on-target properties, acceptable plasma exposure and brain penetration, as well as negligible displacement to orthosteric sites of ∼50 GPCRs and transporters. Furthermore, compound 13 suppressed novelty-induced locomotor activity in a 5-HT2CR-dependent manner, suggesting 5-HT2CR PAM, but not 5-HT2AR, activity at the level of the whole organism at the employed doses of 13. We discovered new selective 5-HT2CR PAMs and first-in-class 5-HT2CR/5-HT2AR dual PAMs that broaden the pharmacological toolbox to explore the biology of these vital receptors.
Collapse
Affiliation(s)
- Jianping Chen
- Center for Addiction Sciences and Therapeutics and Chemical Biology Program and Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States
| | - Erik J. Garcia
- Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States
| | - Christina R. Merritt
- Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States
| | - Joshua C. Zamora
- Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States
| | - Andrew A. Bolinger
- Center for Addiction Sciences and Therapeutics and Chemical Biology Program and Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States
| | - Konrad Pazdrak
- Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States
| | - Susan J. Stafford
- Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States
| | - Randy C. Mifflin
- Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States
| | - Eric A. Wold
- Center for Addiction Sciences and Therapeutics and Chemical Biology Program and Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States
| | - Christopher T. Wild
- Center for Addiction Sciences and Therapeutics and Chemical Biology Program and Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States
| | - Haiying Chen
- Center for Addiction Sciences and Therapeutics and Chemical Biology Program and Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States
| | - Noelle C. Anastasio
- Center for Addiction Sciences and Therapeutics and Chemical Biology Program and Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States
| | - Kathryn A. Cunningham
- Center for Addiction Sciences and Therapeutics and Chemical Biology Program and Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States
| | - Jia Zhou
- Center for Addiction Sciences and Therapeutics and Chemical Biology Program and Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States
| |
Collapse
|
2
|
Davis-Reyes BD, Campbell VM, Land MA, Chapman HL, Stafford SJ, Anastasio NC. Profile of cortical N-methyl-D-aspartate receptor subunit expression associates with inherent motor impulsivity in rats. Biochem Pharmacol 2019; 168:204-213. [PMID: 31295463 PMCID: PMC6733662 DOI: 10.1016/j.bcp.2019.07.007] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2019] [Accepted: 07/07/2019] [Indexed: 01/01/2023]
Abstract
Impulsivity is a multifaceted behavioral manifestation with implications in several neuropsychiatric disorders. Glutamate neurotransmission through the N-methyl-D-aspartate receptors (NMDARs) in the medial prefrontal cortex (mPFC), an important brain region in decision-making and goal-directed behaviors, plays a key role in motor impulsivity. We discovered that inherent motor impulsivity predicted responsiveness to D-cycloserine (DCS), a partial NMDAR agonist, which prompted the hypothesis that inherent motor impulsivity is associated with the pattern of expression of cortical NMDAR subunits (GluN1, GluN2A, GluN2B), specifically the protein levels and synaptosomal trafficking of the NMDAR subunits. Outbred male Sprague-Dawley rats were identified as high (HI) or low (LI) impulsive using the one-choice serial reaction time task. Following phenotypic identification, mPFC synaptosomal protein was extracted from HI and LI rats to assess the expression pattern of the NMDAR subunits. Synaptosomal trafficking and stabilization for the GluN2 subunits were investigated by co-immunoprecipitation for postsynaptic density 95 (PSD95) and synapse associated protein 102 (SAP102). HI rats had lower mPFC GluN1 and GluN2A, but higher GluN2B and pGluN2B synaptosomal protein expression versus LI rats. Further, higher GluN2B:PSD95 and GluN2B:SAP102 protein:protein interactions were detected in HI versus LI rats. Thus, the mPFC NMDAR subunit expression pattern and/or synaptosomal trafficking associates with high inherent motor impulsivity. Increased understanding of the complex regulation of NMDAR balance within the mPFC as it relates to inherent motor impulsivity may lead to a better understanding of risk factors for impulse-control disorders.
Collapse
Affiliation(s)
- Brionna D Davis-Reyes
- Center for Addiction Research and Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA
| | - Veronica M Campbell
- Center for Addiction Research and Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA
| | - Michelle A Land
- Center for Addiction Research and Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA
| | - Holly L Chapman
- Center for Addiction Research and Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA
| | - Susan J Stafford
- Center for Addiction Research and Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA
| | - Noelle C Anastasio
- Center for Addiction Research and Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA.
| |
Collapse
|
3
|
Rayavara K, Kurosky A, Stafford SJ, Garg NJ, Brasier AR, Garofalo RP, Hosakote YM. Proinflammatory Effects of Respiratory Syncytial Virus-Induced Epithelial HMGB1 on Human Innate Immune Cell Activation. J Immunol 2018; 201:2753-2766. [PMID: 30275049 DOI: 10.4049/jimmunol.1800558] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/23/2018] [Accepted: 08/29/2018] [Indexed: 01/21/2023]
Abstract
High mobility group box 1 (HMGB1) is a multifunctional nuclear protein that translocates to the cytoplasm and is subsequently released to the extracellular space during infection and injury. Once released, it acts as a damage-associated molecular pattern and regulates immune and inflammatory responses. Respiratory syncytial virus (RSV) is a major cause of acute lower respiratory tract infections in infants and elderly, for which no effective treatment or vaccine is currently available. This study investigated the effects of HMGB1 on cytokine secretion, as well as the involvement of NF-κB and TLR4 pathways in RSV-induced HMGB1 release in human airway epithelial cells (AECs) and its proinflammatory effects on several human primary immune cells. Purified HMGB1 was incubated with AECs (A549 and small alveolar epithelial cells) and various immune cells and measured the release of proinflammatory mediators and the activation of NF-κB and P38 MAPK. HMGB1 treatment significantly increased the phosphorylation of NF-κB and P38 MAPK but did not induce the release of cytokines/chemokines from AECs. However, addition of HMGB1 to immune cells did significantly induce the release of cytokines/chemokines and activated the NF-κB and P38 MAPK pathways. We found that activation of NF-κB accounted for RSV-induced HMGB1 secretion in AECs in a TLR4-dependent manner. These results indicated that HMGB1 secreted from AECs can facilitate the secretion of proinflammatory mediators from immune cells in a paracrine mechanism, thus promoting the inflammatory response that contributes to RSV pathogenesis. Therefore, blocking the proinflammatory function of HMGB1 may be an effective approach for developing novel therapeutics.
Collapse
Affiliation(s)
- Kempaiah Rayavara
- Department of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, TX 77555
| | - Alexander Kurosky
- Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX 77555
| | - Susan J Stafford
- Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX 77555
| | - Nisha J Garg
- Department of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, TX 77555
| | - Allan R Brasier
- Division of Endocrinology, Department of Internal Medicine, The University of Texas Medical Branch, Galveston, TX 77555.,Institute for Translational Sciences, The University of Texas Medical Branch, Galveston, TX 77555
| | - Roberto P Garofalo
- Department of Pediatrics, The University of Texas Medical Branch, Galveston, TX 77555; and.,Sealy Center for Vaccine Development, The University of Texas Medical Branch, Galveston, TX 77555
| | - Yashoda M Hosakote
- Department of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, TX 77555; .,Institute for Translational Sciences, The University of Texas Medical Branch, Galveston, TX 77555
| |
Collapse
|
4
|
Soman KV, Stafford SJ, Pazdrak K, Wu Z, Luo X, White WI, Wiktorowicz JE, Calhoun WJ, Kurosky A. Activation of Human Peripheral Blood Eosinophils by Cytokines in a Comparative Time-Course Proteomic/Phosphoproteomic Study. J Proteome Res 2017; 16:2663-2679. [PMID: 28679203 DOI: 10.1021/acs.jproteome.6b00367] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Activated eosinophils contribute to airway dysfunction and tissue remodeling in asthma and thus are considered to be important factors in asthma pathology. We report here comparative proteomic and phosphoproteomic changes upon activation of eosinophils using eight cytokines individually and in selected cytokine combinations in time-course reactions. Differential protein and phosphoprotein expressions were determined by mass spectrometry after 2-dimensional gel electrophoresis (2DGE) and by LC-MS/MS. We found that each cytokine-stimulation produced significantly different changes in the eosinophil proteome and phosphoproteome, with phosphoproteomic changes being more pronounced and having an earlier onset. Furthermore, we observed that IL-5, GM-CSF, and IL-3 showed the greatest change in protein expression and phosphorylation, and this expression differed markedly from those of the other five cytokines evaluated. Comprehensive univariate and multivariate statistical analyses were employed to evaluate the comparative results. We also monitored eosinophil activation using flow cytometry (FC) analysis of CD69. In agreement with our proteomic studies, FC indicated that IL-5, GM-CSF, and IL-3 were more effective than the other five cytokines studied in stimulating a cell surface CD69 increase indicative of eosinophil activation. Moreover, selected combinations of cytokines revealed proteomic patterns with many proteins in common with single cytokine expression patterns but also showed a greater effect of the two cytokines employed, indicating a more complex signaling pathway that was reflective of a more typical inflammatory pathology.
Collapse
Affiliation(s)
- Kizhake V Soman
- Department of Biochemistry & Molecular Biology, University of Texas Medical Branch , Galveston, Texas 77555, United States.,Sealy Center for Molecular Medicine, University of Texas Medical Branch , Galveston, Texas 77555, United States
| | - Susan J Stafford
- Department of Biochemistry & Molecular Biology, University of Texas Medical Branch , Galveston, Texas 77555, United States
| | - Konrad Pazdrak
- Department of Biochemistry & Molecular Biology, University of Texas Medical Branch , Galveston, Texas 77555, United States.,Sealy Center for Molecular Medicine, University of Texas Medical Branch , Galveston, Texas 77555, United States.,Institute for Translational Sciences, University of Texas Medical Branch , Galveston, Texas 77555, United States
| | - Zheng Wu
- Department of Biochemistry & Molecular Biology, University of Texas Medical Branch , Galveston, Texas 77555, United States
| | - Xuemei Luo
- Department of Biochemistry & Molecular Biology, University of Texas Medical Branch , Galveston, Texas 77555, United States
| | - Wendy I White
- MedImmune LLC , One MedImmune Way, Gaithersburg, Maryland 20878, United States
| | - John E Wiktorowicz
- Department of Biochemistry & Molecular Biology, University of Texas Medical Branch , Galveston, Texas 77555, United States.,Sealy Center for Molecular Medicine, University of Texas Medical Branch , Galveston, Texas 77555, United States.,Institute for Translational Sciences, University of Texas Medical Branch , Galveston, Texas 77555, United States.,Institute for Human Immunity & Infection, University of Texas Medical Branch , Galveston, Texas 77555, United States
| | - William J Calhoun
- Department of Internal Medicine, University of Texas Medical Branch , Galveston, Texas 77555, United States
| | - Alexander Kurosky
- Department of Biochemistry & Molecular Biology, University of Texas Medical Branch , Galveston, Texas 77555, United States.,Sealy Center for Molecular Medicine, University of Texas Medical Branch , Galveston, Texas 77555, United States
| |
Collapse
|
5
|
Serda RE, Blanco E, Mack A, Stafford SJ, Amra S, Li Q, van de Ven A, Tanaka T, Torchilin VP, Wiktorowicz JE, Ferrari M. Proteomic analysis of serum opsonins impacting biodistribution and cellular association of porous silicon microparticles. Mol Imaging 2011; 10:43-55. [PMID: 21303614 PMCID: PMC4154307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023] Open
Abstract
Mass transport of drug delivery vehicles is guided by particle properties, such as size, shape, composition, and surface chemistry, as well as biomolecules and serum proteins that adsorb to the particle surface. In an attempt to identify serum proteins influencing cellular associations and biodistribution of intravascularly injected particles, we used two-dimensional gel electrophoresis and mass spectrometry to identify proteins eluted from the surface of cationic and anionic silicon microparticles. Cationic microparticles displayed a 25-fold greater abundance of Ig light variable chain, fibrinogen, and complement component 1 compared to their anionic counterparts. Anionic microparticles were found to accumulate in equal abundance in murine liver and spleen, whereas cationic microparticles showed preferential accumulation in the spleen. Immunohistochemistry supported macrophage uptake of both anionic and cationic microparticles in the liver, as well as evidence of association of cationic microparticles with hepatic endothelial cells. Furthermore, scanning electron micrographs supported cellular competition for cationic microparticles by endothelial cells and macrophages. Despite high macrophage content in the lungs and tumor, microparticle uptake by these cells was minimal, supporting differences in the repertoire of surface receptors expressed by tissue-specific macrophages. In summary, particle surface chemistry drives selective binding of serum components impacting cellular interactions and biodistribution.
Collapse
Affiliation(s)
- Rita E Serda
- Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX 77030, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Serda RE, Blanco E, Mack A, Stafford SJ, Amra S, Li Q, van de Ven A, Tanaka T, Torchilin VP, Wiktorowicz JE, Ferrari M. Proteomic Analysis of Serum Opsonins Impacting Biodistribution and Cellular Association of Porous Silicon Microparticles. Mol Imaging 2011. [DOI: 10.2310/7290.2011.00008] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Affiliation(s)
- Rita E. Serda
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Elvin Blanco
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Aaron Mack
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Susan J. Stafford
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Sarah Amra
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Qingpo Li
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Anne van de Ven
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Takemi Tanaka
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Vladimir P. Torchilin
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - John E. Wiktorowicz
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Mauro Ferrari
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| |
Collapse
|
7
|
Serda RE, Blanco E, Mack A, Stafford SJ, Amra S, Li Q, van de Ven A, Tanaka T, Torchilin VP, Wiktorowicz JE, Ferrari M. Proteomic Analysis of Serum Opsonins Impacting Biodistribution and Cellular Association of Porous Silicon Microparticles. Mol Imaging 2011. [DOI: 10.2310/7290.2011.00008s] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Affiliation(s)
- Rita E. Serda
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Elvin Blanco
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Aaron Mack
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Susan J. Stafford
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Sarah Amra
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Qingpo Li
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Anne van de Ven
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Takemi Tanaka
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Vladimir P. Torchilin
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - John E. Wiktorowicz
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| | - Mauro Ferrari
- From the Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, TX; Biomolecular Resource Facility and Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Bioengineering, Rice University, Houston, TX
| |
Collapse
|
8
|
Straub C, Pazdrak K, Young TW, Stafford SJ, Wu Z, Wiktorowicz JE, Haag AM, English RD, Soman KV, Kurosky A. Toward the Proteome of the Human Peripheral Blood Eosinophil. Proteomics Clin Appl 2009; 3:1151-1173. [PMID: 21048890 DOI: 10.1002/prca.200900043] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
Eosinophils are granular leukocytes that have significant roles in many inflammatory and immunoregulatory responses, especially asthma and allergic diseases. We have undertaken a fairly comprehensive proteomic analysis of purified peripheral blood eosinophils from normal human donors primarily employing 2-dimensional gel electrophoresis with protein spot identification by matrix-assisted laser desorption/ionization mass spectrometry. Protein subfractionation methods employed included isoelectric focusing (Zoom(®) Fractionator) and subcellular fractionation using differential protein solubilization. We have identified 3,141 proteins which had Mascot expectation scores of 10(-3) or less. Of these 426 were unique and non-redundant of which 231 were novel proteins not previously reported to occur in eosinophils. Ingenuity Pathway Analysis showed that some 70% of the non-redundant proteins could be subdivided into categories that are clearly related to currently known eosinophil biological activities. Cytoskeletal and associated proteins predominated among the proteins identified. Extensive protein posttranslational modifications were evident, many of which have not been previously reported that reflected the dynamic character of the eosinophil. This dataset of eosinophilic proteins will prove valuable in comparative studies of disease versus normal states and for studies of gender differences and polymorphic variation among individuals.
Collapse
Affiliation(s)
- Christof Straub
- Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Goplen N, Gorska MM, Stafford SJ, Rozario S, Guo L, Liang Q, Alam R. A phosphosite screen identifies autocrine TGF-beta-driven activation of protein kinase R as a survival-limiting factor for eosinophils. J Immunol 2008; 180:4256-64. [PMID: 18322238 DOI: 10.4049/jimmunol.180.6.4256] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
The differential usage of signaling pathways by chemokines and cytokines in eosinophils is largely unresolved. In this study, we investigate signaling similarities and differences between CCL11 (eotaxin) and IL-5 in a phosphosite screen of human eosinophils. We confirm many previously known pathways of cytokine and chemokine signaling and elucidate novel phosphoregulation in eosinophils. The signaling molecules that were stimulated by both agents were members of the ERK1/2 and p38 MAPK pathways and their downstream effectors such as RSK and MSK1/2. Both agents inhibited S6 kinase, protein kinase Cepsilon, and glycogen synthase kinase 3 alpha and beta. The molecules that were differentially regulated include STATs and protein kinase R (PKR). One of the chief findings in this investigation was that PKR and eukaryotic initiation factor 2alpha are phosphorylated under basal conditions in eosinophils and neutrophils. This basal phosphorylation was linked to autocrine secretion of TGF-beta in eosinophils. TGF-beta directly activates PKR in eosinophils. Basal phosphorylation of PKR was inhibited by incubation of eosinophils with a neutralizing anti-TGF-beta Ab suggesting its physiological importance. We show that inhibition of PKR activity prolongs eosinophil survival. The eosinophil survival factor IL-5 strongly suppresses phosphorylation of PKR. The biological relevance of IL-5 inhibition of phospho-PKR was established by the observation that ex vivo bone marrow-derived eosinophils from OVA-immunized mice had no PKR phosphorylation in contrast to the high level of phosphorylation in sham-immunized mice. Together, our findings suggest that survival of eosinophils is in part controlled by basal activation of PKR through autocrine TGF-beta and that this could be modulated by a Th2 microenvironment in vivo.
Collapse
Affiliation(s)
- Nicholas Goplen
- National Jewish Medical and Research Center, Denver, CO 80206, USA
| | | | | | | | | | | | | |
Collapse
|
10
|
Abstract
Leprosy was first recorded in 600 bc in India. Europe saw its first cases in the fourteenth century. The worldwide incidence is falling, but the disease can still present in the most unexpected places: this is a report of the first case of leprosy presenting to an emergency department in Northern Ireland. It is important for physicians in both community and hospital medicine to have a high index of suspicion for leprosy in patients with chronic skin conditions who were born outside the UK or other developed countries.
Collapse
Affiliation(s)
- S J Stafford
- Emergency Department, Craigavon Area Hospital, 68 Lurgan Road, Portadown, BT63 5QQ, United Kingdom.
| | | |
Collapse
|
11
|
Gorska MM, Liang Q, Stafford SJ, Goplen N, Dharajiya N, Guo L, Sur S, Gaestel M, Alam R. MK2 controls the level of negative feedback in the NF-kappaB pathway and is essential for vascular permeability and airway inflammation. ACTA ACUST UNITED AC 2007; 204:1637-52. [PMID: 17576778 PMCID: PMC2118652 DOI: 10.1084/jem.20062621] [Citation(s) in RCA: 83] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
We demonstrate that mitogen-activated protein kinase-activated kinase-2 (MK2) is essential for localized Th2-type inflammation and development of experimental asthma. MK2 deficiency does not affect systemic Th2 immunity, but reduces endothelial permeability, as well as adhesion molecule and chemokine expression. NF-kappaB regulates transcription of adhesion molecules and chemokines. We show that MK2 and its substrate HSP27 are essential for sustained NF-kappaB activation. MK2 and HSP27 prevent nuclear retention of p38 by sequestering it in the cytosol. As a result, MK2 precludes excessive phosphorylation of MSK1. By reducing MSK1 activity, MK2 prevents p65 NF-kappaB hyperphosphorylation and excessive IkappaBalpha transcription. IkappaBalpha mediates nuclear export of p65. By reducing IkappaBalpha level, MK2 prevents premature export of NF-kappaB from the nucleus. Thus, the MK2-HSP27 pathway regulates the NF-kappaB transcriptional output by switching the activation pattern from high level, but short lasting, to moderate-level, but long lasting. This pattern of activation is essential for many NF-kappaB-regulated genes and development of inflammation. Thus, the MK2-HSP27 pathway is an excellent target for therapeutic control of localized inflammatory diseases.
Collapse
Affiliation(s)
- Magdalena M Gorska
- Division of Allergy and Immunology, Department of Medicine, National Jewish Medical and Research Center, Denver, CO 80206, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Abstract
Through the yeast two-hybrid screen we have identified dynamin-2 as a molecule that interacts with the alpha subunit of the interleukin (IL) 5 receptor. Dynamin-2 is a GTPase that is critical for endocytosis. We have shown that dynamin-2 interacts with the IL-5 receptor-associated tyrosine kinases, Lyn and JAK2, in eosinophils. Tyrosine phosphorylation of dynamin is markedly enhanced upon IL-5 stimulation. The inhibition of tyrosine kinases results in complete abolition of ligand-induced receptor endocytosis. Inhibition of dynamin by a dominant-negative mutant or by small interfering RNA results in enhancement of IL-5-stimulated ERK1/2 signaling and cell proliferation. In contrast, the absence of a functional dynamin does not affect STAT5 or AKT phosphorylation or cell survival. Thus, we have identified specific functions for dynamin in the IL-5 signaling pathway and demonstrated its role in receptor endocytosis and termination of the ERK1/2 signaling pathway.
Collapse
Affiliation(s)
- Magdalena M Gorska
- Division of Allergy and Immunology, Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado 80206, USA
| | | | | | | | | |
Collapse
|
13
|
|
14
|
Stafford SJ, Schwimer J, Anthony CT, Thomson JL, Wang YZ, Woltering EA. Colchicine and 2-methoxyestradiol Inhibit Human Angiogenesis. J Surg Res 2005; 125:104-8. [PMID: 15836858 DOI: 10.1016/j.jss.2004.11.017] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2004] [Revised: 11/18/2004] [Accepted: 11/19/2004] [Indexed: 11/21/2022]
Abstract
BACKGROUND Angiogenesis is a critical determinant of tumor growth and the development of metastases. Tubulin inhibitors have been shown to be effective inhibitors of angiogenesis. We hypothesized that colchicine, a well-know tubulin inhibitor and 2-methoxyestradiol (2 MeOH), a novel tubulin inhibitor, would limit the initiation of a human angiogenic response and would limit subsequent neovessel growth in a dose-dependent manner. METHODS To test this hypothesis, we cultured full-thickness human placental vein discs from three placentas in a fibrin-thrombin clot model. Both colchicine and 2 MeOH were tested over a wide range of concentrations (10(-6) to 10(-12) M) to determine their effect on the percent of wells that initiated an angiogenic response (%I) and the subsequent growth (Angiogenic Index, 0-16 range) of vein-derived neovessels. RESULTS Colchicine at doses of 10(-6) and 10(-8) M completely inhibited the angiogenic response (CI: 95%, P < 0.0001) but lower (10(-10) to 10(-12) M) doses did not significantly inhibit angiogenesis (P = NS). Effective in vitro colchicine levels far exceed achievable non-toxic human plasma levels. In contrast, 2-methoxyestradiol decreased initiation and angiogenic growth significantly at 10(-6) M (CI: 95%, P < 0.0001), but did not significantly decrease angiogenesis at doses of 10(-8), 10(-10), or 10(-12) M. In contrast to colchicine, human plasma levels of 10(-6) M 2 MeOH are achievable clinically with little or no associated toxicity. CONCLUSIONS Effective in vitro drug levels of 2 MeOH can be achieved in vivo, suggesting that 2 MeOH may have a role in the clinical treatment of angiogenesis-dependent diseases.
Collapse
Affiliation(s)
- S J Stafford
- Department of Surgery, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA
| | | | | | | | | | | |
Collapse
|
15
|
Abstract
The first step in T cell receptor for antigen (TCR) signaling is the activation of the receptor-bound Src kinases, Lck and Fyn. The exact mechanism of this process is unknown. Here, we report that the novel Src homology (SH) 3/SH2 ligand–Uncoordinated 119 (Unc119) associates with CD3 and CD4, and activates Lck and Fyn. Unc119 overexpression increases Lck/Fyn activity in T cells. In Unc119-deficient T cells, Lck/Fyn activity is dramatically reduced with concomitant decrease in interleukin 2 production and cellular proliferation. Reconstitution of cells with Unc119 reverses the signaling and functional outcome. Thus, Unc119 is a receptor-associated activator of Src-type kinases. It provides a novel mechanism of signal generation in the TCR complex.
Collapse
Affiliation(s)
- Magdalena M Gorska
- Division of Allergy and Immunology, Department of Internal Medicine, University of Texas Medical Branch, Galveston 77555, USA
| | | | | | | | | |
Collapse
|
16
|
Abstract
Lyn, an Src-type tyrosine kinase, is associated with the interleukin (IL)-5 receptor in eosinophils. The mechanism of its activation is unknown. Through yeast two-hybrid screening we have cloned and characterized a new signaling molecule, Unc119, that associates with IL-5Ralpha and Src family tyrosine kinases. Unc119 induces the catalytic activity of these kinases through interaction with Src homology 2 and 3 domains. IL-5 stimulation of eosinophils increases Unc119 association with Lyn and induces its catalytic activity. Lyn is important for eosinophil survival. Eosinophils that are transduced with Unc119 have increased Lyn activity and demonstrate prolonged survival in the absence of IL-5. Inhibition of Unc119 down-regulates eosinophil survival. To our knowledge Unc119 is the first receptor-associated activator of Src family tyrosine kinases.
Collapse
Affiliation(s)
- Osman Cen
- Division of Allergy and Immunology, NIAID, National Institutes of Health Asthma and Allergic Diseases Research Center, Bethesda, Maryland 20892, USA
| | | | | | | | | |
Collapse
|
17
|
Abstract
Protein disulfide isomerase (PDI) exhibits both an oxido-reductase and an isomerase activity on proteins containing cysteine residues. These activities arise from two active sites, both of which contain pairs of redox active cysteines. We have developed two simple in vivo assays for these activities of PDI, based on the demonstration that PDI can complement both a dsbA mutation and a dsbC mutation when expressed to the periplasm of Escherichia coli. We constructed a variety of mutants in and around the active sites of PDI and analysed them using these complementation assays. Our analysis showed that the active site amino acid residues have a major role in determining the activities exhibited by PDI, particularly the N-terminal cysteine of the N-terminal active site. The roles of the histidine residue at position 38 and the glutamic acid residue at position 30 were also studied using these assays. The results show that these two in vivo assays should be useful for rapid screening of mutants in PDI prior to purification and detailed biochemical analysis.
Collapse
Affiliation(s)
- S J Stafford
- School of Biosciences, University of Birmingham, Edgbaston, UK
| | | |
Collapse
|
18
|
Stafford SJ, Humphreys DP, Lund PA. Mutations in dsbA and dsbB, but not dsbC, lead to an enhanced sensitivity of Escherichia coli to Hg2+ and Cd2+. FEMS Microbiol Lett 1999; 174:179-84. [PMID: 10234837 DOI: 10.1111/j.1574-6968.1999.tb13566.x] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
The Dsb proteins are involved in disulfide bond formation, reduction and isomerisation in a number of Gram-negative bacteria. Mutations in dsbA or dsbB, but not dsbC, increase the proportion of proteins with free thiols in the periplasm compared to wild-type. We investigated the effects of mutations in these genes on the bacterial resistance to mercuric and cadmium salts. Mutations in genes involved primarily in disulfide formation (dsbA and dsbB) generally enhanced the sensitivity to Hg2+ and Cd2+ while a mutation of the dsbC gene (primarily an isomerase of disulfide bonds) had no effect. Mutations of the dsb genes had no effect on the expression of the mercury-resistance determinants of the transposon Tn501.
Collapse
Affiliation(s)
- S J Stafford
- School of Biological Sciences, University of Birmingham, Edgbaston, UK
| | | | | |
Collapse
|
19
|
Shorte SL, Stafford SJ, Collett VJ, Schofield JG. Simultaneous measurement of [Ca2+]i and secretion-coupled membrane turnover, by single cell fluorescence microscopy. Cell Calcium 1995; 18:440-54. [PMID: 8581972 DOI: 10.1016/0143-4160(95)90059-4] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Thyrotropin releasing hormone (TRH), which stimulates prolactin secretion, increases the fluorescence of cultured bovine anterior pituitary (bAP) cells in the presence of the non-permeant membrane indicator dye FM 1-43 [Stafford SJV. Shorte SL. Schofield JG. (1993) Use of a fluorescent dye to measure secretion from intact bovine anterior pituitary cells. Biosci. Rep., 13, 9-17]. FM 1-43 is non-fluorescent in aqueous solution but becomes fluorescent when incorporated into the plasma membrane. The membrane area accessible to FM 1-43 dye, and therefore cell fluorescence, increases during exocytosis as secretory granules fuse with the plasma membrane, and endocytosis as vesicles formed at the plasma-membrane fuse with intracellular organelle membranes. We have here measured changes in FM 1-43 uptake and the intracellular calcium concentration ([Ca2+]i) concurrently in the same cells on exposure to TRH, phorbol myristate acetate (PMA) or NH4Cl. TRH (0.1-10 microM) caused a transient increase in [Ca2+]i in 70-90% of bAP cells and in 60-90% of the responding cells also caused a sustained increased FM 1-43 fluorescence. TRH increased [Ca2+]i but did not affect FM 1-43 fluorescence in GH3 rat pituitary cells, probably because they contain too few secretory granules to give a detectable increase. The dopamine D2-receptor agonist quinpirole (10 microM) had little effect on the TRH-induced [Ca2+]i rise in bAP cells, but abolished the increase in FM 1-43 fluorescence. The phorbol ester PMA (0.3-3 microM) caused a small, transient increase in [Ca2+]i followed by a fall to levels lower than original resting levels in 40-60% of bAP cells and increased FM 1-43 uptake in cells showing these changes. Extracellular NH4Cl, which mobilises calcium from an ionomycin-insensitive calcium store, caused a transient [Ca2+]i increase in over 90% of the bAP-cells and increased FM 1-43 uptake in a subpopulation (> 50%) of these. The Na+/H+ ionophore monensin prevented the increase in FM 1-43 fluorescence but not the [Ca2+]i rise induced by TRH, prevented the increases in both FM 1-43 fluorescence and [Ca2+]i caused by NH4Cl, and reduced the number of cells showing a rise in FM 1-43 fluorescence in response to PMA from 64% to 34%. The Ca(2+)-ATPase inhibitor thapsigargin reduced the number of bAP cells displaying TRH-induced increases in [Ca2+]i and membrane-turnover from 74% to 18%, but did not affect the changes in [Ca2+]i or FM 1-43 fluorescence caused by PMA or NH4Cl. We discuss the relationships between the secretogogue-induced increases in FM 1-43 fluorescence and changes in intracellular [Ca2+]i under these conditions.
Collapse
Affiliation(s)
- S L Shorte
- Department of Biochemistry, University of Bristol, UK
| | | | | | | |
Collapse
|
20
|
Stafford SJ. A question of validity. N C Med J 1994; 55:5. [PMID: 8121504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
|
21
|
Shorte SL, Stafford SJ, Bamford M, Collett VJ, Schofield JG. Thyroliberin-induced changes in the fluorescence of a membrane probe in individual bovine anterior pituitary cells. J Physiol 1993; 470:191-210. [PMID: 8308725 PMCID: PMC1143913 DOI: 10.1113/jphysiol.1993.sp019854] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
1. We have investigated the use of TMA-DPH (1-[4-(trimethylammonio) phenyl]-6-phenylhexa-1,3,5-triene) as an indicator of exocytosis in individual bovine anterior pituitary cells using microfluorimetric imaging. 2. TMA-DPH was photolabile in artificial and cell membranes. In cells incubated in TMA-DPH the distribution of fluorescence depended both on the incubation time and the illumination schedule. If the dye was added while the cells were subjected to repeated cycles of 0.36 s light intermittent with 1-15 s dark, the fluorescence of the peripheral annulus and the central region of individual cells rose in parallel and reached a steady state within 200 s; the annulus was always brighter than the central region. However, using long intervening dark periods (200 s), the central region continued to incorporate dye after the annulus had reached a plateau. 3. When the cells were loaded with TMA-DPH using intermittent light with short dark periods, the dye washed out of the central region and the annulus in parallel when external dye was removed. However, if the cells had been loaded using long dark periods, the dye was washed out of the central region more slowly than from the annulus. 4. When cells were incubated in TMA-DPH in the dark for 1 min and then exposed to constant illumination in the presence of external dye, the fluorescence of the central region and the annulus both decayed in parallel to a new steady state. If the cells were incubated in TMA-DPH in the dark for 240 min the fluorescence from each region fell to a steady state but the falls were larger and were not in parallel. 5. We suggest that TMA-DPH fluorescence was derived from plasma membrane-associated and internalized dye and that the amount of fluorescence from the latter varied because TMA-DPH was photobleached. Thus, when illumination was interrupted by short dark intervals, annular fluorescence was high compared to central fluorescence because bleached dye in the plasma membrane was rapidly replaced by unbleached dye from the medium. However, long dark intervals permitted the dye to be internalized before it was bleached and fluorescence was therefore also present in central regions. 6. The total cell fluorescence, observed using 15 s dark intervals, was increased 5-40% (in single cells) in a dose-dependent fashion by addition of TRH (tripeptide thyrotrophin-releasing hormone; 1-200 nM).(ABSTRACT TRUNCATED AT 400 WORDS)
Collapse
Affiliation(s)
- S L Shorte
- Department of Biochemistry, School of Medical Sciences, University of Bristol
| | | | | | | | | |
Collapse
|
22
|
Stafford SJ, Schofield JG. Membrane trafficking in pituitary cells: studies using a fluorescent dye. Biochem Soc Trans 1993; 21 ( Pt 3):320S. [PMID: 8224465 DOI: 10.1042/bst021320s] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Affiliation(s)
- S J Stafford
- Department of Biochemistry, School of Medical Sciences, Bristol University, U.K
| | | |
Collapse
|
23
|
Abstract
The fluorescent dye FM1-43 has been used to indicate membrane changes in individual bovine anterior pituitary cells exposed to secretory stimuli. After ten minutes incubation with FM1-43 (2 microM), cells showed three patterns of dye fluorescence: annular, partly filled and uniformly filled. FM1-43 fluorescence was increased in 61% of the cells by TRH (40 nM), a physiological stimulus for prolactin secretion, and in 89% of the cells by 60 mM external K+. The fluorescence also increased when cells incubated in the presence of quinpirole, a dopamine D2-receptor agonist which inhibits prolactin secretion, were exposed to raclopride, a D-2 antagonist. The increases in FM1-43 fluorescence caused by these treatments suggests that the dye acts as an indicator of secretion, possibly through incorporation into secretory vesicle membranes exposed on the cell surface during exocytosis. If the dye was washed away after loading, the fluorescence of partly and uniformly filled cells was retained and a rise in fluorescence could still be seen on stimulation by TRH. This suggests that some dye had been taken up by endocytosis and trapped in an intracellular compartment, which expanded through membrane recapture after TRH stimulation. FM1-43 could therefore be a useful probe for membrane cycling associated with secretory responses.
Collapse
Affiliation(s)
- S J Stafford
- Department of Biochemistry, School of Medical Sciences, University of Bristol
| | | | | |
Collapse
|
24
|
Beckman WC, Fried FA, Stafford SJ, Mickey DD. Autoradiographic localization of tritium-labeled dihydrotestosterone in human vas deferens. J Androl 1986; 7:197-202. [PMID: 3722002 DOI: 10.1002/j.1939-4640.1986.tb00911.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
The human vas deferens was examined autoradiographically for the presence and distribution of androgen receptors. Samples of vas deferens from the region proximal to the testis and the region at the internal inguinal ring were incubated in vitro with tritium-labeled dihydrotestosterone ([3H]-DHT). Frozen sections of tissue were mounted on autoradiographic emulsion-coated slides and exposed for up to three weeks to demonstrate cells with nuclear accumulations of radioactive hormone. Quantitation of autoradiograms was performed with a Zeiss Videoplan morphometric analysis system. Cells in all five tissue layers of the vas deferens were able to bind androgen receptors in the nucleus, as evidenced by superimposition of silver grains over the nuclei of cells in external, middle, and internal smooth muscle layers, as well as in epithelial and subepithelial stromal cells.
Collapse
|
25
|
Abstract
We report on a 13-year-old white body with familial visceral myopathy. The abnormalities of the gastrointestinal and urinary tracts are described and the literature regarding urologic implications of this disorder is reviewed.
Collapse
|
26
|
Abstract
Early diagnosis and intervention in the child with myelodysplasia can effectively improve and preserve renal function in those newborns presenting with abnormalities at birth or who are at risk for deterioration of renal function from infection, vesicoureteral reflux and/or obstruction. During a 1-year period 10 newborns with myelodysplasia were seen. Hydronephrosis was present in 6, reflux in 3 and urinary tract infection in 3. In each newborn adequate decompression of the bladder and complete resolution of the hydronephrosis were achieved. Uroradiographic evaluation was helpful in determining the best mode of therapy for each individual.
Collapse
|
27
|
Stafford SJ, Jenkins JM, Staab EV, Boyce I, Fried FA. Ultrasonic detection of renal calculi: accuracy tested in an in vitro porcine kidney model. J Clin Ultrasound 1981; 9:359-363. [PMID: 6792234 DOI: 10.1002/jcu.1870090703] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
Porcine kidneys containing human calculi of known size and composition were used to study the ability of ultrasound to localize intrarenal calculi. The study conducted in a blind fashion demonstrated that stones as small as 2 mm could be detected. The chemical composition was not related to the ability to detect the stone. Early trials in the operating room have been encouraging. The porcine kidney model is useful for training purposes.
Collapse
|